Fluconazole and phenytoin: a predictable interaction.
作者信息
Mitchell A S, Holland J T
机构信息
Department of Neurology, Royal Newcastle Hospital, New South Wales, Australia.
出版信息
BMJ. 1989 May 13;298(6683):1315. doi: 10.1136/bmj.298.6683.1315-b.
Abstract
摘要
相似文献
1
Fluconazole and phenytoin: a predictable interaction.氟康唑与苯妥英钠：一种可预测的相互作用。
BMJ. 1989 May 13;298(6683):1315. doi: 10.1136/bmj.298.6683.1315-b.
2
Interaction of fluconazole and cyclosporine.
Ann Intern Med. 1989 May 15;110(10):844. doi: 10.7326/0003-4819-110-10-844_1.
3
Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men.健康男性同时服用泊沙康唑和苯妥英后的药物相互作用评估。
Curr Med Res Opin. 2007 Jun;23(6):1415-22. doi: 10.1185/030079907X187937. Epub 2007 May 11.
4
Hypokalaemia in patients with acute myeloid leukaemia after treatment with fluconazole.
Lancet. 1989 May 6;1(8645):1017. doi: 10.1016/s0140-6736(89)92657-3.
5
Fluconazole-induced symptomatic phenytoin toxicity.氟康唑诱发的症状性苯妥英中毒。
Ann Pharmacother. 1994 Feb;28(2):191-5. doi: 10.1177/106002809402800206.
6
Safety of triazole antifungal drugs in patients with cancer.癌症患者使用三唑类抗真菌药物的安全性。
J Antimicrob Chemother. 2010 Mar;65(3):410-6. doi: 10.1093/jac/dkp464. Epub 2009 Dec 24.
7
Posaconazole prophylaxis in hematologic cancer.
N Engl J Med. 2007 May 24;356(21):2215; author reply 2215-8.
8
Treatment of aspergillosis.
Clin Infect Dis. 2008 Aug 1;47(3):427; author reply 427-8. doi: 10.1086/589923.
9
[Fluconazole treatment of systemic mycoses].
Jpn J Antibiot. 1989 Jan;42(1):55-62.
10
Traditional and emerging antifungal therapies.传统和新兴的抗真菌治疗方法。
Proc Am Thorac Soc. 2010 May;7(3):222-8. doi: 10.1513/pats.200906-048AL.
引用本文的文献
1
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.抗真菌药物的药代动力学：优化患者治疗的实际意义。
Infection. 2017 Dec;45(6):737-779. doi: 10.1007/s15010-017-1042-z. Epub 2017 Jul 12.
2
Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.抗真菌药物对氧化药物代谢的影响：临床相关性。
Clin Pharmacokinet. 2000 Feb;38(2):111-80. doi: 10.2165/00003088-200038020-00002.
3
Systemic antifungal agents. Drug interactions of clinical significance.全身性抗真菌药物。具有临床意义的药物相互作用。
Drug Saf. 1998 Feb;18(2):83-97. doi: 10.2165/00002018-199818020-00001.
4
Clinical pharmacokinetics of fluconazole.氟康唑的临床药代动力学
Clin Pharmacokinet. 1993 Jan;24(1):10-27. doi: 10.2165/00003088-199324010-00002.
5
Antiepileptic drugs. A review of clinically significant drug interactions.抗癫痫药物。具有临床意义的药物相互作用综述。
Drug Saf. 1993 Sep;9(3):156-84. doi: 10.2165/00002018-199309030-00003.
6
Pharmacokinetic drug interactions with antimicrobial agents.药物与抗菌药物的药代动力学相互作用。
Clin Pharmacokinet. 1993 Dec;25(6):450-82. doi: 10.2165/00003088-199325060-00005.
7
Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.氟康唑。对其药效学和药代动力学特性以及在浅表和全身性真菌病中的治疗潜力的综述。
Drugs. 1990 Jun;39(6):877-916. doi: 10.2165/00003495-199039060-00006.
8
Pharmacokinetic drug interactions with phenytoin (Part II).苯妥英的药代动力学药物相互作用（第二部分）。
Clin Pharmacokinet. 1990 Feb;18(2):131-50. doi: 10.2165/00003088-199018020-00004.
9
Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections.氟康唑。抗真菌药物治疗人类免疫缺陷病毒感染机会性真菌病的综述及现状。
Pharm Weekbl Sci. 1991 Apr 26;13(2):45-57. doi: 10.1007/BF01974981.
10
Adverse drug reactions to systemic antifungals. Prevention and management.全身性抗真菌药物的药物不良反应。预防与管理。
Drug Saf. 1992 Sep-Oct;7(5):323-63. doi: 10.2165/00002018-199207050-00003.
本文引用的文献
1
Fluconazole in the treatment of candidal prosthetic valve endocarditis.氟康唑治疗念珠菌性人工瓣膜心内膜炎。
BMJ. 1988 Jul 16;297(6642):178-9. doi: 10.1136/bmj.297.6642.178.
2
Azole antifungal agents: emphasis on new triazoles.唑类抗真菌药物：重点介绍新型三唑类药物。
Antimicrob Agents Chemother. 1988 Jan;32(1):1-8. doi: 10.1128/AAC.32.1.1.
Zotero 插件